Vitamin C has long been debated as a potential cancer treatment, but researchers now understand that how it is delivered may make a major difference. While earlier studies using vitamin C pills showed little benefit, intravenous vitamin C can produce much higher concentrations in the body. At these levels, vitamin C may act differently and potentially damage certain cancer cells. Early research suggests intravenous vitamin C could also help reduce some treatment-related side effects and possibly improve outcomes for certain patients. However, these findings remain under investigation, and vitamin C should not be considered a proven standalone cancer treatment. Larger clinical trials are needed to determine which patients may benefit most.
Read more at ScienceDaily